Global Ambulatory Blood Pressure Monitors Market - 2024-2031

Overview

The global Ambulatory blood pressure monitors market reached US$ 1.20 billion in 2023 and is expected to reach US$ 2.43 billion by 2031 growing with a CAGR of 9.2% during the forecast period 2024-2031.

Ambulatory blood pressure monitoring (ABPM) is a diagnostic method that measures a patient's blood pressure at regular intervals over 24 hours while they carry out their usual daily activities. This approach offers a more precise depiction of blood pressure variations compared to conventional office measurements, as it records fluctuations at different times throughout the day and night.

Ambulatory blood pressure monitoring (ABPM) devices consist of a portable monitor linked to a cuff worn on the arm or wrist, which automatically inflates at designated intervals to capture blood pressure readings Ambulatory blood pressure monitoring is a valuable and thorough method for assessing and managing hypertension. Delivering continuous, real-time data on blood pressure variations, improves diagnostic precision and enables healthcare providers to make well-informed treatment decisions, ultimately leading to better patient outcomes in managing hypertension.

Market Dynamics: Drivers

Rising prevalence of hypertension

The demand for the global ambulatory blood pressure monitors market is driven by multiple factors. The increasing prevalence of hypertension is a key factor propelling the ambulatory blood pressure monitoring (ABPM) market. With millions of individuals affected worldwide and an aging population at greater risk, there is an urgent demand for reliable blood pressure monitoring solutions. Advances in technology, rising health awareness, and supportive government programs further demand for the ABPM market.

Hypertension is a significant contributor to premature mortality globally. One of the international goals for noncommunicable diseases is to achieve a 33% reduction in the prevalence of hypertension between 2010 and 2030. As per WHO data in March 2023, an estimated 1.28 billion adults aged 30 to 79 years worldwide suffer from hypertension, with approximately two-thirds residing in low- and middle-income countries. About 46% of adults with hypertension are unaware of their condition, and less than half (42%) have been diagnosed and treated. Only 21% of those with hypertension manage to keep it under control.

Moreover, key players in the industry have technological advancements and product launches that would drive this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in October 2022, Biobeat is revolutionizing the 24-hour ambulatory blood pressure monitoring (ABPM) experience for both hypertension patients and healthcare providers through its innovative cuffless monitoring technology. This advancement addresses several limitations associated with traditional blood pressure monitoring methods.

Also, in May 2021, Biobeat, a prominent name in wearable remote patient monitoring technologies, has recently unveiled a new device specifically designed for continuous ambulatory blood pressure monitoring (ABPM) that can be worn comfortably on the chest. This advanced chest-monitoring device allows healthcare professionals to continuously track patients' blood pressure, significantly improving the ability to monitor vital signs outside conventional clinical environments.

Restraints

Factors such as the high costs of devices, limited reimbursement policies, and complications associated with use are expected to hamper the ambulatory blood pressure monitoring (ABPM) market.

Segment Analysis

The global ambulatory blood pressure monitors market is segmented based on product type, operation type, end-user, and region.

The arm monitors segment accounted for approximately 73.2% of the global ambulatory blood pressure monitors market share

The arm monitors segment is expected to hold the largest market share over the forecast period. Arm monitors are widely regarded as more accurate than wrist monitors for measuring blood pressure. They use a standard cuff that wraps around the upper arm, which is the recommended site for obtaining reliable readings. This level of accuracy makes them the preferred option for clinicians who need precise data for diagnosis and treatment.

Additionally, arm ambulatory blood pressure monitoring (ABPM) devices have been extensively utilized in clinical settings for many years. Their established presence in hospitals and clinics lends credibility to their use among healthcare professionals, leading to a continued preference for these devices over newer wrist models. Advancements in ambulatory blood pressure monitoring (ABPM) technology have greatly changed the field of blood pressure measurement, resulting in the creation of more compact and user-friendly devices, such as wrist and arm monitors.

Moreover, key players in the industry introduce innovative products and approvals that would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, one of the major players SunTech Medical launched the Oscar 2 ambulatory blood pressure monitor is esteemed as the leading device in 24-hour ambulatory blood pressure monitoring (ABPM).

It is designed to deliver essential diagnostic data that traditional in-clinic and home blood pressure monitors often miss, making it an invaluable resource for healthcare professionals. The device emphasizes patient comfort through its patented Orbit ABPM cuff, which is designed with a soft and flexible material that fits snugly around the arm. This design allows patients to wear the monitor for long durations without discomfort, encouraging greater compliance with monitoring protocols.

Similarly, The BPro EVO from HealthSTATS International is a third-generation ambulatory blood pressure monitor (ABPM) that integrates several advanced features aimed at improving patient monitoring and enhancing data accuracy.

Also, in October 2024, Huawei introduced the Watch D2 a smartwatch that sets itself apart with its sophisticated health monitoring features, particularly through its Ambulatory Blood Pressure Monitoring (ABPM) capability. This technology allows users to continuously monitor their blood pressure around the clock, providing critical insights into their cardiovascular health.

Geographical Analysis

North America accounted for approximately 43.2% of the global ambulatory blood pressure monitors market share

North America region is expected to hold the largest market share over the forecast period. The high prevalence of hypertension in North America significantly influences the ambulatory blood pressure monitors (ABPM) market. Hypertension, commonly referred to as high blood pressure, elevates the risk of heart disease and stroke, which are among the leading causes of death in the United States.

Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in August 2022, CardiAI Inc. officially launched its new 24-hour ambulatory blood pressure monitoring system, named BPAro. This device is compact and portable, manufactured in Germany, and designed for individuals to monitor their blood pressure. Utilizing Bluetooth technology, BPAro wirelessly collects data, which is then securely uploaded to a cloud database for analysis.

Market Segmentation

By Product Type

• Arm Monitors
  • Digital Arm Monitors
  • Aneroid Arm Monitors
  • Mercury Arm Monitors
• Wrist Monitors (Digital Wrist Monitors)

By Operation Type

• Automatic Monitors
• Semi-Automatic Monitors
• Manual Monitors

By End-User

• Hospitals & Specialty Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • The rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the ambulatory blood pressure monitors market include Spacelabs Healthcare., BOSCH + SOHN GmbH Co. KG., SunTech Medical, Inc., Schiller AG, Baxter International Inc. (Welch Allyn, BPL Medical Technologies, A&D Company, Microlife Corporation, CONTEC MEDICAL SYSTEMS CO., LTD, and Vaso Corporation among others.

Key Developments

• In March 2024, seca Screen 300 ABPM was introduced as a state-of-the-art ambulatory blood pressure monitor (ABPM), recognized for its cutting-edge features and significant validation. It is distinguished as the first ABPM device in the world to achieve successful validation under the European Society of Hypertension International Protocol (ESH-IP) 2010 standards.

Why Purchase the Report?

• To visualize the global ambulatory blood pressure monitors market segmentation based on product type, operation type, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points on the ambulatory blood pressure monitors market in all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global ambulatory blood pressure monitors market report would provide approximately 62 tables, 51 figures, and 183 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies